TY - JOUR AU - S. Afaq A1 - AB - In recent years, research on TB multimorbidity has increasingly focused on integrated care delivery, particularly concerning common mental disorders (CMDs). Engagement with relevant stakeholders, including service users and providers, has highlighted the critical intersection of TB and CMD, which affects a substantial percentage of individuals. Studies have found that depression affects approximately 45% of TB patients, and anxiety affects around 40%. Moreover, there is a significant evidence and service gap in delivering CMD care, which emphasises the need for a comprehensive approach to address the dual burden of these health challenges. AD - Department of Health Sciences, University of York, Heslington, York, UK; , Khyber Medical University (KMU), Institute of Public Health & Social Sciences (IPH&SS), Peshawar, Pakistan. AN - 39578362 BT - Int J Tuberc Lung Dis C5 - Medically Unexplained Symptoms CP - 12 DA - Dec 1 DO - 10.5588/ijtld.24.0438 DP - NLM IS - 12 JF - Int J Tuberc Lung Dis LA - eng N2 - In recent years, research on TB multimorbidity has increasingly focused on integrated care delivery, particularly concerning common mental disorders (CMDs). Engagement with relevant stakeholders, including service users and providers, has highlighted the critical intersection of TB and CMD, which affects a substantial percentage of individuals. Studies have found that depression affects approximately 45% of TB patients, and anxiety affects around 40%. Moreover, there is a significant evidence and service gap in delivering CMD care, which emphasises the need for a comprehensive approach to address the dual burden of these health challenges. PY - 2024 SN - 1027-3719 SP - 561 EP - 563+ ST - A comprehensive person-centred TB care model, from malnutrition to mental health T1 - A comprehensive person-centred TB care model, from malnutrition to mental health T2 - Int J Tuberc Lung Dis TI - A comprehensive person-centred TB care model, from malnutrition to mental health U1 - Medically Unexplained Symptoms U3 - 10.5588/ijtld.24.0438 VL - 28 VO - 1027-3719 Y1 - 2024 ER -